Work

CD3+ tumor-infiltrating lymphocytes (TILs) as prognostic in patients (pts) with stage II colon cancer (CC) not treated with adjuvant chemotherapy (ADJ).

Year: 2020

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2020.38.4_suppl.167

Authors: Edoardo Francini, Fang-Shu Ou, Stefano Lazzi, Roberto Petrioli, Andrea Giovanni Multari, Guido Pesola, Luciana Messuti, Elena Colombo, Virginia Livellara, Serena Bazzurri, Sara Cherri, Miano Salvatora, Eric Wolfe, Steven R Alberts, Joleen Marie Hubbard, Harry H. Yoon, Guido Francini

Institutions: Ospedale Misericordia - Grosseto, Mayo Clinic, Ospedale Santa Maria alle Scotte, Azienda Ospedaliera Universitaria Senese

Language: English

Topic: Colorectal Cancer Surgical Treatments

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W3005519211

Cites:

Cited by:

Related to: 10